C12N 2760/18751
Methods of production or purification of viral material
C12N2760/18751 (Methods of production or purification of viral material) appears on 8 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 8
- Published applications
- 7
- Assignees
- 11
- Inventors
- 24
- Latest grant
- 23 May 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 1 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Engineered cells with decreased gene expression resulting in increased viral production23 May 2023US 11,655,471 B2University of Georgia Research Foundation, Inc.
- Attenuated parainfluenza virus (PIV) vaccines31 May 2011US 7,951,383 B2The United States of America as represented by the Department of Health and Human Services
- Stabilizers for live vaccines15 May 2001US 6,231,860 B1Pasteur Merieux Serums & Vaccins
- Method for producing an adapted virus population from an African green monkey kidney cell line12 Sep 2000US 6,117,667 ADyncorp
- Method for producing a virus from an african green monkey kidney cell line15 Feb 2000US 6,025,182 ADyncorp
- Method of producing negative-strand rna virus vector and produced negative-strand rna virus vector27 Aug 2026US 2026/0250709 A1Repli-Tech Co., Ltd.
- Viral vectors3 Jul 2025US 2025/0213674 A1City, University of London
- Method of producing negative-strand rna virus vector and produced negative-strand rna virus vector19 Sep 2024US 2024/0309335 A1Repli-Tech Co., Ltd.
- Methods and compositions related to increased viral production9 Jan 2020US 2020/0010830 A1University of Georgia Research Foundation, Inc.
- Attenuated parainfluenza virus (PIV) vaccines24 Apr 2008US 2008/0096264 A1Government of the US, as represented by the Secretary, Dept. of Health and Human Services
Most cited
By later US patents
- Production of viruses in tissue culture without use of serum39US 4,072,565 AThe Dow Chemical Company · 1978
- Stabilizers for live vaccines25US 6,231,860 B1Pasteur Merieux Serums & Vaccins · 2001
- Attenuated parainfluenza virus (PIV) vaccines11US 7,951,383 B2The United States of America as represented by the Department of Health and Human Services · 2011
- Method of producing a virus vaccine from an African green monkey kidney cell line4US 5,911,998 ADyncorp · 1999
- African green monkey kidney cell lines useful for maintaining viruses and for preparation of viral vaccines1US 5,646,033 ADyncorp · 1997